Please Wait

Applying Filters...

Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

Dexmedetomidine

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

48 API Suppliers, 19 USDMF, 5 JDMF, 5 EU WC, 13 KDMF, 17 NDC API, 8 VMF, 32 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

45 Drugs in Development

45 Drugs in Development

FINISHED DOSAGE FORMULATIONS

103 FDF Dossiers, 60 FDA Orange Book, 6 Europe, 17 Canada, 9 South Africa, 11 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - EQ 1MG BASE/10ML (EQ 100MCG BASE/ML), SOLUTION;INTRAVENOUS - EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML), SOLUTION;INTRAVENOUS - EQ 400MCG BASE/4ML (EQ 100MCG BASE/ML), SOLUTION;INTRAVENOUS - EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML), INJECTABLE;INJECTION - EQ 1MG BASE/250ML (EQ 4MCG BASE/ML), INJECTABLE;INJECTION - EQ 200MCG BASE/2ML (EQ 100MCG BASE/ML), INJECTABLE;INJECTION - EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML), INJECTABLE;INJECTION - EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML), INJECTABLE;INJECTION - EQ 80MCG BASE/20ML (EQ 4MCG BASE/ML)

RELATED EXCIPIENT COMPANIES

2 Actylis

2 Actylis

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 54 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 Regulatory FDF Prices, 4 Annual Reports

MARKET PLACE

21 APIs, 8 FDF Dossiers

PATENTS & EXCLUSIVITIES

70 US Patents, 9 US Exclusivities, 3 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 USP, 1 Others

$ Xls download

Filters

Log in to access your PharmaMiles and download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Labeler	NDC Package Code	Non Proprietary Name	Start Marketing Date	End Marketing Date	Category Code	Dosage Form (Strength)
28/03/2025	Fermion Oy	Finland	Fermion Oy	12780-4640	Dexmedetomidine Hydrochloride	1998-10-30	2025-12-31	BULK INGREDIENT	POWDER (1kg/kg)
28/03/2025	Interquim SA	Spain	Interquim S.A. de C.V.	40074-0004	Dexmedetomidine HCI	2018-11-19	2025-12-31	BULK INGREDIENT	POWDER (1g/g)

Contact us
to update this info

Dexmedetomidine

Dexmedetomidine

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

48 API Suppliers

19 USDMF

5 JDMF

5 EU WC

13 KDMF

17 NDC API

8 VMF

32 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

45 Drugs in Development

FINISHED DOSAGE FORMULATIONS

103 FDF Dossiers

60 FDA Orange Book

6 Europe

17 Canada

9 South Africa

11 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - EQ 1MG BASE/10ML (EQ 100MCG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 400MCG BASE/4ML (EQ 100MCG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML)

INJECTABLE;INJECTION - EQ 1MG BASE/250ML (EQ 4MCG BASE/ML)

INJECTABLE;INJECTION - EQ 200MCG BASE/2ML (EQ 100MCG BASE/ML)

INJECTABLE;INJECTION - EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML)

INJECTABLE;INJECTION - EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML)

INJECTABLE;INJECTION - EQ 80MCG BASE/20ML (EQ 4MCG BASE/ML)

RELATED EXCIPIENT COMPANIES

2 Actylis

DIGITAL CONTENT

2 Data Compilation #PharmaFlow

54 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 Regulatory FDF Prices

4 Annual Reports

MARKET PLACE

21 APIs

8 FDF Dossiers

PATENTS & EXCLUSIVITIES

70 US Patents

9 US Exclusivities

3 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 USP

1 Others

Filters